Dashboard
Manage Tickers

CHECHEMED CORP

NYSE chemed.com


$ 568.96 $ -6.45 (-1.12 %)    

Monday, 13-May-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 442.92 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.64 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.56 $ -2.45 (-1.12 %)
$ 568.79
$ 574.57
$ 0.00 x 0
$ 0.00 x 0
$ 568.85 - $ 575.55
$ 492.17 - $ 654.62
55,500
na
8.72B
$ 0.69
$ 30.79
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-29-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 10-27-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 04-28-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 07-29-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-01-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-04-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-02-2018 09-30-2018 10-Q
24 07-30-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-26-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-31-2017 06-30-2017 10-Q
29 04-28-2017 03-31-2017 10-Q
30 02-27-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 07-29-2016 06-30-2016 10-Q
33 05-02-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-31-2015 06-30-2015 10-Q
37 05-01-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 07-30-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

peering-into-chemeds-recent-short-interest
Peering Into Chemed's Recent Short Interest
05/02/2024 16:00:22

chemed-sees-fy24-eps-2330-2370-vs-2352-est
Chemed Sees FY24 EPS $23.30-$23.70 Vs $23....
04/24/2024 20:34:33

Guidance for 2024Management reiterates its estimated full-year 2024 earnings per diluted share, excluding: non-cash expense for...

chemed-q1-adj-520-misses-548-estimate-sales-58923m-miss-59146m-estimate
Chemed Q1 Adj $5.20 Misses $5.48 Estimate,...
04/24/2024 20:20:06

Chemed (NYSE:CHE) reported quarterly earnings of $5.20 per share which missed the analyst consensus estimate of $5.48 by 5.11 p...

vitas-a-wholly-owned-subsidiary-of-chemed-to-buy-hospice-assets-of-covenant-care-in-florida-and-alabama-for-an-aggregate-purchase-price-of-85m
VITAS, A Wholly-Owned Subsidiary Of Chemed...
03/13/2024 13:12:51

VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it enter...

che---analyzing-chemeds-short-interest
(CHE) - Analyzing Chemed's Short Interest
03/04/2024 17:45:25

rbc-capital-maintains-outperform-on-chemed-raises-price-target-to-712
RBC Capital Maintains Outperform on Chemed...
03/04/2024 15:24:34

RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and raises the price target from $604 to $712.

oppenheimer-maintains-outperform-on-chemed-raises-price-target-to-650
Oppenheimer Maintains Outperform on Chemed...
02/29/2024 15:37:56

Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:CHE) with a Outperform and raises the price target from $625 t...

chemed-q4-2023-adj-eps-660-beats-625-estimate-sales-58591m-miss-58664m-estimate
Chemed Q4 2023 Adj EPS $6.60 Beats $6.25 E...
02/27/2024 22:58:25

Chemed (NYSE:CHE) reported quarterly earnings of $6.60 per share which beat the analyst consensus estimate of $6.25 by 5.6 perc...

chemed-q4-earnings-insights
Chemed: Q4 Earnings Insights
02/27/2024 21:25:49

earnings-scheduled-for-february-27-2024
Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

chemed-dividend-insights
Chemed: Dividend Insights
02/20/2024 14:45:19

oppenheimer-maintains-outperform-on-chemed-raises-price-target-to-625
Oppenheimer Maintains Outperform on Chemed...
01/17/2024 15:58:45

Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:CHE) with a Outperform and raises the price target from $590 t...

chemed-corporation-announces-the-appointment-of-michael-d-witzeman-as-cfo-effective-january-1-2024-following-the-retirement-of-david-p-williams-from-that-role
Chemed Corporation Announces The Appointme...
12/18/2023 18:26:08

Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Fi...

chemed-form4-filing-shows-cfo-patrick-david-williams-sold-6000-shares-at-an-average-price-of-58385-per-share
Chemed Form4 Filing Shows CFO Patrick Davi...
11/08/2023 16:40:27

- SEC Filing

chemed-dividend-insights
Chemed: Dividend Insights
11/07/2023 14:45:14

chemed-corporations-board-of-directors-authorizes-an-additional-300m-for-stock-repurchase
Chemed Corporation's Board Of Directors Au...
11/06/2023 14:06:12

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million fo...

chemed-corporation-announces-the-retirement-of-cfo-david-p-williams-on-december-31-2023
Chemed Corporation Announces The Retiremen...
11/03/2023 20:19:21

Chemed Corporation (NYSE:CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Wi...

rbc-capital-maintains-outperform-on-chemed-raises-price-target-to-604
RBC Capital Maintains Outperform on Chemed...
10/30/2023 17:23:30

RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and raises the price target from $576 to $604.

ibm-servicenow-lennox-morningstar-and-other-big-stocks-moving-higher-on-thursday
IBM, ServiceNow, Lennox, Morningstar And O...
10/26/2023 15:55:18

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking t...

chemed-corporation-sees-fy23-eps-1982-2002-vs-1998-est
Chemed Corporation Sees FY23 EPS $19.82-$2...
10/25/2023 20:56:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION